Neogen Corporation (NEOG)
USD 11.64
(-4.04%)
USD 11.64
(-4.04%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 906.23 Million USD | 0.69% |
| 2023 | 900 Million USD | -8.79% |
| 2022 | 986.68 Million USD | 76613.0% |
| 2021 | 1.28 Million USD | 21.93% |
| 2020 | 1.05 Million USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 9.95 Million USD | 0.0% |
| 2005 | - USD | -100.0% |
| 2004 | 3.9 Million USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | -100.0% |
| 2001 | 77 Thousand USD | -86.63% |
| 2000 | 576 Thousand USD | 476.0% |
| 1999 | 100 Thousand USD | -50.0% |
| 1998 | 200 Thousand USD | -33.33% |
| 1997 | 300 Thousand USD | -78.57% |
| 1996 | 1.4 Million USD | -12.5% |
| 1995 | 1.6 Million USD | 1500.0% |
| 1994 | 100 Thousand USD | -75.0% |
| 1993 | 400 Thousand USD | -20.0% |
| 1992 | 500 Thousand USD | -16.67% |
| 1991 | 600 Thousand USD | -25.0% |
| 1990 | 800 Thousand USD | -61.9% |
| 1989 | 2.1 Million USD | -16.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 889.48 Million USD | 0.07% |
| 2024 FY | 906.23 Million USD | 0.69% |
| 2024 Q4 | 906.23 Million USD | 1.8% |
| 2024 Q3 | 890.17 Million USD | 0.08% |
| 2024 Q1 | 888.81 Million USD | 0.38% |
| 2023 FY | 900 Million USD | -8.79% |
| 2023 Q3 | 884.7 Million USD | -4.25% |
| 2023 Q2 | 923.96 Million USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q4 | 885.43 Million USD | 0.08% |
| 2022 Q3 | 2.78 Million USD | 27.51% |
| 2022 FY | 986.68 Million USD | 76613.0% |
| 2022 Q4 | 986.68 Million USD | 35379.61% |
| 2022 Q2 | 2.18 Million USD | -9.43% |
| 2022 Q1 | 2.4 Million USD | 87.22% |
| 2021 Q3 | 1.08 Million USD | 2.54% |
| 2021 Q2 | 1.06 Million USD | 9.94% |
| 2021 FY | 1.28 Million USD | 21.93% |
| 2021 Q1 | 966 Thousand USD | 5.81% |
| 2021 Q4 | 1.28 Million USD | 18.11% |
| 2020 FY | 1.05 Million USD | 0.0% |
| 2020 Q2 | 1.45 Million USD | 48.27% |
| 2020 Q3 | 1.46 Million USD | 0.76% |
| 2020 Q4 | 913 Thousand USD | -37.76% |
| 2020 Q1 | 982 Thousand USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2018 Q3 | 16.37 Million USD | -27.03% |
| 2018 Q4 | - USD | -100.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q2 | 22.43 Million USD | 0.0% |
| 2017 Q3 | - USD | -100.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q2 | 18.66 Million USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 FY | - USD | -100.0% |
| 2007 Q1 | - USD | -100.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 Q3 | 12.8 Million USD | 0.0% |
| 2006 FY | 9.95 Million USD | 0.0% |
| 2006 Q4 | 9.95 Million USD | -22.23% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q1 | 2.4 Million USD | -38.46% |
| 2005 Q2 | 2.45 Million USD | 2.38% |
| 2005 Q3 | 2.25 Million USD | -8.42% |
| 2005 Q4 | - USD | -100.0% |
| 2005 FY | - USD | -100.0% |
| 2004 Q4 | 3.9 Million USD | -15.22% |
| 2004 FY | 3.9 Million USD | 0.0% |
| 2004 Q3 | 4.6 Million USD | 48.39% |
| 2004 Q2 | 3.1 Million USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2002 Q1 | 65 Thousand USD | -15.58% |
| 2002 FY | - USD | -100.0% |
| 2002 Q2 | 53 Thousand USD | -18.46% |
| 2002 Q3 | 41 Thousand USD | -22.64% |
| 2002 Q4 | - USD | -100.0% |
| 2001 Q1 | 113 Thousand USD | -80.38% |
| 2001 Q4 | 77 Thousand USD | -14.44% |
| 2001 Q3 | 90 Thousand USD | -10.89% |
| 2001 Q2 | 101 Thousand USD | -10.62% |
| 2001 FY | 77 Thousand USD | -86.63% |
| 2000 Q1 | 100 Thousand USD | 0.0% |
| 2000 Q4 | 576 Thousand USD | -2.04% |
| 2000 FY | 576 Thousand USD | 476.0% |
| 2000 Q3 | 588 Thousand USD | 488.0% |
| 2000 Q2 | 100 Thousand USD | 0.0% |
| 1999 FY | 100 Thousand USD | -50.0% |
| 1999 Q4 | 100 Thousand USD | 0.0% |
| 1999 Q3 | 100 Thousand USD | -50.0% |
| 1999 Q2 | 200 Thousand USD | 0.0% |
| 1999 Q1 | 200 Thousand USD | 0.0% |
| 1998 Q1 | 300 Thousand USD | 0.0% |
| 1998 Q4 | 200 Thousand USD | 0.0% |
| 1998 Q3 | 200 Thousand USD | -33.33% |
| 1998 Q2 | 300 Thousand USD | 0.0% |
| 1998 FY | 200 Thousand USD | -33.33% |
| 1997 Q1 | 1.4 Million USD | 0.0% |
| 1997 Q4 | 300 Thousand USD | 0.0% |
| 1997 Q3 | 300 Thousand USD | 0.0% |
| 1997 Q2 | 300 Thousand USD | -78.57% |
| 1997 FY | 300 Thousand USD | -78.57% |
| 1996 Q3 | 1.7 Million USD | 0.0% |
| 1996 Q4 | 1.4 Million USD | -17.65% |
| 1996 Q2 | 1.7 Million USD | 21.43% |
| 1996 FY | 1.4 Million USD | -12.5% |
| 1996 Q1 | 1.4 Million USD | -12.5% |
| 1995 Q4 | 1.6 Million USD | 0.0% |
| 1995 FY | 1.6 Million USD | 1500.0% |
| 1994 Q2 | 400 Thousand USD | 33.33% |
| 1994 FY | 100 Thousand USD | -75.0% |
| 1994 Q4 | 100 Thousand USD | 0.0% |
| 1994 Q1 | 300 Thousand USD | -25.0% |
| 1993 Q1 | 400 Thousand USD | -20.0% |
| 1993 FY | 400 Thousand USD | -20.0% |
| 1993 Q4 | 400 Thousand USD | 0.0% |
| 1992 Q4 | 500 Thousand USD | 0.0% |
| 1992 FY | 500 Thousand USD | -16.67% |
| 1991 FY | 600 Thousand USD | -25.0% |
| 1991 Q4 | 600 Thousand USD | 0.0% |
| 1990 Q4 | 800 Thousand USD | 0.0% |
| 1990 FY | 800 Thousand USD | -61.9% |
| 1989 FY | 2.1 Million USD | -16.0% |
| 1989 Q4 | 2.1 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bionano Genomics, Inc. | 87.94 Million USD | -930.438% |
| Prenetics Global Limited | 2.36 Million USD | -38147.809% |
| Star Equity Holdings, Inc. | 3.6 Million USD | -25010.529% |
| CareDx, Inc | 34.22 Million USD | -2548.196% |
| Exact Sciences Corporation | 2.55 Billion USD | 64.527% |
| Exagen Inc. | 23.72 Million USD | -3720.408% |
| Inotiv, Inc. | 417.64 Million USD | -116.99% |
| Guardant Health, Inc. | 1.35 Billion USD | 33.058% |
| Biodesix, Inc. | 60.69 Million USD | -1393.202% |
| BioNexus Gene Lab Corp. | 133.39 Thousand USD | -679265.044% |
| Precipio, Inc. | 1.11 Million USD | -81104.211% |
| iSpecimen Inc. | 196.24 Thousand USD | -461691.953% |
| Natera, Inc. | 441.99 Million USD | -105.035% |
| Aspira Women's Health Inc. | 2.26 Million USD | -39892.895% |
| Standard BioTools Inc. | 98.21 Million USD | -822.756% |
| 23andMe Holding Co. | 76.51 Million USD | -1084.394% |
| Castle Biosciences, Inc. | 15.31 Million USD | -5819.262% |
| Personalis, Inc. | 48.96 Million USD | -1750.903% |
| Aclaris Therapeutics, Inc. | 426 Thousand USD | -212632.16% |
| Applied DNA Sciences, Inc. | 1.23 Million USD | -73116.052% |
| OpGen, Inc. | 13.04 Million USD | -6847.711% |
| T2 Biosystems, Inc. | 49.49 Million USD | -1730.86% |
| Myriad Genetics, Inc. | 145 Million USD | -524.992% |
| ICON Public Limited Company | 3.93 Billion USD | 76.989% |
| NeoGenomics, Inc. | 611.67 Million USD | -48.156% |
| Star Equity Holdings, Inc. | 3.6 Million USD | -25010.529% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | 4.393% |
| RadNet, Inc. | 1.49 Billion USD | 39.224% |
| MDxHealth SA | 41.26 Million USD | -2096.144% |
| Psychemedics Corporation | 2.29 Million USD | -39335.988% |
| Illumina, Inc. | 2.26 Billion USD | 59.936% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 94.06 Million USD | -863.377% |
| DarioHealth Corp. | 29.54 Million USD | -2967.733% |
| Fulgent Genetics, Inc. | 14.9 Million USD | -5979.285% |
| Sera Prognostics, Inc. | 1.85 Million USD | -48674.973% |
| ENDRA Life Sciences Inc. | 394.4 Thousand USD | -229674.875% |
| OPKO Health, Inc. | 326.56 Million USD | -177.507% |
| Medpace Holdings, Inc. | 142.12 Million USD | -537.649% |
| Intelligent Bio Solutions Inc. | 871.44 Thousand USD | -103893.275% |
| Prenetics Global Limited | 2.36 Million USD | -38147.809% |
| Mainz Biomed B.V. | 7.42 Million USD | -12112.18% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | -57306.348% |
| Trinity Biotech plc | 67.42 Million USD | -1244.03% |
| Neuronetics, Inc. | 62.47 Million USD | -1350.586% |
| Sotera Health Company | 2.32 Billion USD | 61.056% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | -57306.348% |